These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 34163207)
1. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma. Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207 [TBL] [Abstract][Full Text] [Related]
2. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma. Gong W; Dai W; Wei H; Chen Y; Zheng Z Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224 [TBL] [Abstract][Full Text] [Related]
3. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker. Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650 [No Abstract] [Full Text] [Related]
4. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma. Zhang X; Wu Z; Ma K BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944 [TBL] [Abstract][Full Text] [Related]
5. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642 [TBL] [Abstract][Full Text] [Related]
6. Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128 [TBL] [Abstract][Full Text] [Related]
7. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma. Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates. Wei Q; Miao T; Zhang P; Jiang B; Yan H Front Genet; 2022; 13():984575. PubMed ID: 36159963 [No Abstract] [Full Text] [Related]
9. Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level. Chen W; Guo Z; Wu J; Lin G; Chen S; Lin Q; Yang J; Xu Y; Zeng Y BMC Cancer; 2022 Jan; 22(1):115. PubMed ID: 35090416 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
11. PHD3 as a Prognosis Marker and its Relationship with Immune Infiltration in Lung Adenocarcinoma. Wang L; Zhong Y; Wang G; An H; Gao Q; Ye Y Comb Chem High Throughput Screen; 2022; 25(13):2255-2263. PubMed ID: 35088661 [TBL] [Abstract][Full Text] [Related]
12. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma. Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050 [TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma. Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886 [TBL] [Abstract][Full Text] [Related]
14. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310 [TBL] [Abstract][Full Text] [Related]
15. Identification of KRT80 as a Novel Prognostic and Predictive Biomarker of Human Lung Adenocarcinoma via Bioinformatics Approaches. Jiang J; Lu J; Feng Y; Zhao Y; Su J; Zeng T; Chen Y; Shen K; Jia Y; Lin S Comb Chem High Throughput Screen; 2024 Jun; ():. PubMed ID: 38910478 [TBL] [Abstract][Full Text] [Related]
16. NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma. Luo L; Li Y; Zhang L; Yang L Technol Health Care; 2024; 32(4):2277-2291. PubMed ID: 38517815 [TBL] [Abstract][Full Text] [Related]
17. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma. Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786 [TBL] [Abstract][Full Text] [Related]
18. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ Front Immunol; 2021; 12():724741. PubMed ID: 34335635 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma. Cai J; Deng H; Luo L; You L; Liao H; Zheng Y Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549 [TBL] [Abstract][Full Text] [Related]
20. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]